Vitamin D insufficiency in a large female SLE cohort

Lupus

Volumn 19, Issue 1, 2010, Pages 13-19

  Toloza, S M A ^a   Cole, D E C ^a   Gladman, D D ^a   Ibanez D ^a   Urowitz, M B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cohort study; SLE; Vitamin D deficiency; Women

Indexed keywords

25 HYDROXYVITAMIN D; ANTIMALARIAL AGENT; CALCITRIOL; CALCIUM; CREATININE; DOUBLE STRANDED DNA ANTIBODY; GLUCOCORTICOID; VITAMIN D;

ADULT; ANTIBODY DETECTION; ARTICLE; BONE DENSITY; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EXPOSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM; SEASONAL VARIATION; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE;

ADULT; CALCITRIOL; COHORT STUDIES; CREATININE; FEMALE; GLUCOCORTICOIDS; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MULTIVARIATE ANALYSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 74849127723     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309345775     Document Type: Article

References (26)

1. Lane NE Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006 ; 10: 562-569.
2. Holick MF Vitamin D deficiency. N Engl J Med 2007 ; 19 ; 357: 266-281.
3. Arnson Y., Amital H., Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007 ; 66: 1137-1142.
4. Bischoff-Ferrari HA Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 2008 ; 624: 55-71.
5. Am Huisman, White KP, Algra A., et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001 ; 28: 2535-2539.
6. Kamen DL, Cooper GS, Bouali H., Shaftman SR, Hollis BW, Gilkeson GS Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006 ; 5: 114-117.
7. Thudi A., Yin S., Wandstrat AE, Li QZ, Olsen NJ Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci 2008 ; 335: 99-104.
8. Ruiz-Irastorza G., Egurbide MV, Olivares N., Martinez-Berriotxoa A., Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology 2008 ; 47: 920-923.
9. Carvalho JF, Blank M., Kiss E., Tarr T., Amital H., Shoenfeld Y. Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci 2007 ; 1109: 550-557.
10. Urowitz MB, Gladman DD Contributions of observational cohort studies in systemic lupus erythematosus: the University of Toronto lupus clinic experience. Rheum Dis Clin North Am 2005 ; 31: 211-221.
11. Siminoski K., Leslie WD, Frame H., et al. Canadian Association of Radiologists. Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 2005 ; 56: 178-188.
12. Vieth R., Cole DE, Hawker GA, Trang HM, Rubin LA Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 2001 ; 55: 1091-1097.
13. Gladman DD, Ibaez D., Urowitz MB Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002 ; 29: 288-291.
14. Gladman D., Ginzler E., Goldman C., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996 ; 39: 363-369.
15. Hagenau T., Vest R., Gissel TN, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 2009 ; 20: 133-140. Epub 2008 May 6).
16. ORegan S., Chesney RW, Hamstra A., Eisman JA, O Gorman AM, Deluca HF Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 1979 ; 68: 109-111.
17. Patschan D., Loddenkemper K., Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 2001 ; 29: 498-505.
18. Lukert BP, Raisz LG Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990 ; 112: 352-364.
19. Kimberg DV, Baerg RD, Gershon E., Graudusius RT Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest 1971 ; 50: 1309-1321.
20. Chesney RW, Mazess RB, Hamstra AJ, DeLuca HF, OReagan S. Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids. Lancet 1978 ; 2: 1123-1125.
21. Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005 ; 52: 2044-2050.
22. BarrÉ PE, Gascon-BarrÉ M., Meakins JL, Goltzman D. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am J Med 1987 ; 82: 1259-1262.
23. DeSimone DP, Brilliant HL, Basile J., Bell NH Granulomatous infiltration of the talus and abnormal vitamin D and calcium metabolism in a patient with sarcoidosis: successful treatment with hydroxychloroquine. Am J Med 1989 ; 87: 694-696.
24. Jones E., Callen JP Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol 1990 ; 23: 487-489.
25. Adams JS, Kantorovich V. Inability of short-term, low-dose hydroxychloroquine to resolve vitamin D-mediated hypercalcemia in patients with B-cell lymphoma. J Clin Endocrinol Metab 1999 ; 84: 799-801.
26. Chen S., Sims GP, Chen XX, Gu YY, Chen S., Lipsky PE Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007 ; 179: 1634-1647.